Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Navari

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The American Journal of Medicine|April 1, 1984
Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplantsR M Navari, C D Buckner, R A Clift, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.
Transplantation|November 1, 1983
Mycobacterial infections in marrow transplant patientsR M Navari, K M Sullivan, S C Springmeyer, et al.
The New England Journal of Medicine|January 23, 1999
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials GroupR M Navari, R R Reinhardt, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasoneM G Kris, K B Pendergrass, R M Navari, et al.
ESMO Open|March 8, 2024
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJ Herrstedt, R Clark-Snow, C H Ruhlmann, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The American Journal of Medicine|April 1, 1984
Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplantsR M Navari, C D Buckner, R A Clift, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.
Transplantation|November 1, 1983
Mycobacterial infections in marrow transplant patientsR M Navari, K M Sullivan, S C Springmeyer, et al.
The New England Journal of Medicine|January 23, 1999
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials GroupR M Navari, R R Reinhardt, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasoneM G Kris, K B Pendergrass, R M Navari, et al.
ESMO Open|March 8, 2024
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJ Herrstedt, R Clark-Snow, C H Ruhlmann, et al.
Pageof 4